ERBB2 and breast carcinoma: In HER-2+ breast cancer, NF-κB was proven to be essential in the HER2-stimulated glutaminase expression, which is a rate-limiting enzyme involved in the metabolism of glutamine and its conversion to glutamate, leading to ATP provision and anabolic processes [127].